KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Change in Receivables (2018 - 2025)

Steris has reported Change in Receivables over the past 8 years, most recently at $15.5 million for Q4 2025.

  • Quarterly results put Change in Receivables at $15.5 million for Q4 2025, up 384.38% from a year ago — trailing twelve months through Dec 2025 was $9.7 million (down 68.17% YoY), and the annual figure for FY2025 was $28.8 million, down 77.5%.
  • Change in Receivables for Q4 2025 was $15.5 million at Steris, up from $5.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for STE hit a ceiling of $109.8 million in Q1 2024 and a floor of -$119.2 million in Q2 2025.
  • Median Change in Receivables over the past 5 years was $20.5 million (2023), compared with a mean of $14.6 million.
  • Biggest five-year swings in Change in Receivables: surged 843.73% in 2021 and later tumbled 153.73% in 2024.
  • Steris' Change in Receivables stood at -$5.6 million in 2021, then surged by 637.71% to $29.9 million in 2022, then plummeted by 47.2% to $15.8 million in 2023, then crashed by 79.73% to $3.2 million in 2024, then skyrocketed by 384.38% to $15.5 million in 2025.
  • The last three reported values for Change in Receivables were $15.5 million (Q4 2025), $5.3 million (Q3 2025), and -$119.2 million (Q2 2025) per Business Quant data.